45 results
To compare two (standard) treatment regimens in patients with KRAS mutated advanced stage NSCLC as first line treatment.
The primary objective is to compare the antitumor activity of LDK378 versus reference chemotherapy
To compare the efficacy of patritumab deruxtecan versus platinumbased chemotherapy, as measured by progression-free survival (PFS), insubjects with metastatic or locally advanced nonsquamous non-small cell lung cancer (NSCLC) with an EGFR-activating…
Objectives:Primary:- Assess safety and tolerability of PDC*lung01 vaccinations administered at two dose levels as single agent or during maintenance treatment by pemetrexed (for adenocarcinomas in Cohorts A1 and A2) or during treatment with anti-PD-…
To assess the safety of cisplatin doublets with hypofractionated radiotherapy (24 x2.75Gy).